Cargando…
Alzheimer's disease biomarkers: another tool for FAA pilot screening?
Research advancements to improve the accuracy of diagnosing Alzheimer's disease (AD) have altered clinicians and researchers’ understanding of the disease process. The discovery of amyloid and tau biomarkers as measures of disease pathology supports early identification of disease risk that pre...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813941/ https://www.ncbi.nlm.nih.gov/pubmed/31666966 http://dx.doi.org/10.1093/jlb/lsz011 |